4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-25-006033
EVP R&D, Chief Medical Officer gave up 3,950 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 8,896 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2025-02-18 | Option exercise | +8,896 | 66,771 | D: show line 1 in the form | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2025-02-18 | Shares withheld for taxes | −3,950 | $35.90 | $141,805 | 62,821 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2025-02-18 | Option exercise · Restricted Stock Unit Award | −8,896 | 8,897 | D: show line 3 in the form | |||||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2025-02-19 | Grant or award · Employee Stock Option (Right to Buy) | +63,991 | 63,991 | D: show line 4 in the form | |||||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2025-02-19 | Grant or award · Restricted Stock Unit Award | +30,692 | 30,692 | D: show line 5 in the form |
Loading xslF345X05/form4.xml…